Evidence map›Paper›PMID 33604706›Full record

ArticleSkeletal radiology2021

Primary osteosarcoma of the parietal bone.

Sara Ramezanpour, Andrew E Horvai, Sorbarikor Piawah, Thomas M Link

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Skeletal radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sara RamezanpourDepartment of Radiology and Biomedical Imaging, University of California, 400 Parnassus Ave, A-367, San Francisco, CA, 94143, USA. Sara.Ramezanpour@ucsf.edu.
Andrew E HorvaiDepartment of Pathology, University of California, San Francisco, CA, USA.
Sorbarikor PiawahDepartment of Medicine, Division of Hematology/Oncology, University of California, San Francisco, CA, USA.
Thomas M LinkDepartment of Radiology and Biomedical Imaging, University of California, 400 Parnassus Ave, A-367, San Francisco, CA, 94143, USA. Thomas.Link@ucsf.edu.
University of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma is the most common primary bone tumor and usually involves the long bones. Osteosarcoma of the skull, on the other hand, is relatively rare. Here, we present a 29-year-old man with a growing mass in the skull he first noticed after a fall while skateboarding. The initial clinical diagnosis was hematoma. While undergoing an evacuation surgery for a hematoma, a suspicious mass was detected which was biopsied. Histopathological evaluation showed high-grade osteosarcoma. The patient was referred to our hospital where he underwent definitive resection followed by adjuvant chemotherapy. His course was complicated by wound infection. Even though osteosarcoma of the skull is a rare finding, it should be suspected in a patient with a skull mass, and the history of prior head trauma does not exclude the diagnosis.

Indexed as

Bone NeoplasmsOsteosarcomaSarcomaSkull NeoplasmsAdultHumansMaleParietal BoneParietal bonePrimary osteosarcomaSkull

Identifiers

PMID33604706
OpenAlexW3129773907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.